Last 7 days
-3.1%
Last 30 days
1.7%
Last 90 days
-22.6%
Trailing 12 Months
3677.8%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2022-08-10 | Cohen Yuval | bought | 1,003 | 0.264 | 3,800 | chief executive officer |
2022-08-10 | Millian Craig Stuart | bought | 1,272 | 0.2545 | 5,000 | chief operating officer |
2022-08-10 | Moran Sean F. | bought | 5,198 | 0.2599 | 20,000 | chief financial officer |
2022-05-16 | Cohen Yuval | bought | 2,625 | 0.25 | 10,500 | chief executive officer |
2022-05-16 | Moran Sean F. | bought | 3,600 | 0.3 | 12,000 | chief financial officer |
2022-03-10 | Millian Craig Stuart | bought | 3,700 | 0.37 | 10,000 | chief operating officer |
2022-03-10 | Moran Sean F. | bought | 5,550 | 0.37 | 15,000 | chief financial officer |
2022-03-09 | Cohen Yuval | bought | 3,182 | 0.37 | 8,600 | chief executive officer |
2020-12-21 | Moran Sean F. | acquired | 122,500 | 1.4 | 87,500 | chief financial officer |
2020-12-21 | Moran Sean F. | sold | -153,125 | 1.75 | -87,500 | chief financial officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -30.65 | -616 | 1,826 | -% |
2023-08-15 | WELLS FARGO & COMPANY/MN | added | 1.27 | 52.00 | 627 | -% |
2023-08-15 | Belpointe Asset Management LLC | sold off | -100 | -160 | - | -% |
2023-08-14 | VANGUARD GROUP INC | added | - | 102,293 | 1,406,940 | -% |
2023-08-14 | Royal Bank of Canada | new | - | 12,000 | 12,000 | -% |
2023-08-14 | Sio Capital Management, LLC | unchanged | - | 85,500 | 1,176,000 | 0.30% |
2023-08-14 | Tower Research Capital LLC (TRC) | reduced | -72.52 | -2,848 | 1,152 | -% |
2023-08-14 | BOOTHBAY FUND MANAGEMENT, LLC | unchanged | - | 21,646 | 297,732 | 0.01% |
2023-08-14 | NewEdge Advisors, LLC | unchanged | - | 5.00 | 63.00 | -% |
2023-08-14 | IFP Advisors, Inc | added | 100 | 24.00 | 34.00 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Aug 24, 2022 | etf managers group, llc | 4.95% | 6,194,679 | SC 13G/A | |
Feb 14, 2022 | etf managers group, llc | 8.78% | 10,995,143 | SC 13G/A | |
Jun 01, 2021 | etf managers group, llc | 11.39% | 14,240,357 | SC 13G/A | |
May 11, 2021 | etf managers group, llc | 5.34% | 6,673,458 | SC 13G/A | |
Apr 12, 2021 | blackrock inc. | 4.5% | 5,673,664 | SC 13G/A | |
Mar 17, 2021 | etf managers group, llc | 4.80% | 5,997,343 | SC 13G/A | |
Feb 16, 2021 | etf managers group, llc | 6.96% | 5,851,347 | SC 13G/A | |
Feb 12, 2021 | etf managers group, llc | 9.28% | 7,796,166 | SC 13G/A | |
Jan 29, 2021 | blackrock inc. | 6.2% | 5,220,525 | SC 13G/A | |
Jan 11, 2021 | state street corp | 1.59% | 1,333,546 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Aug 08, 2023 | 8-K | Current Report | |
Aug 08, 2023 | 10-Q | Quarterly Report | |
Aug 03, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABBV | 269.9B | 56.0B | 3.85% | 7.89% | 31.08 | 4.82 | -2.31% | -31.27% |
BGNE | 262.3B | 1.8B | -6.03% | 32.32% | -151.4 | 144.85 | 69.45% | 14.65% |
VRTX | 90.1B | 9.5B | -0.31% | 22.07% | 26.78 | 9.48 | 13.83% | 5.33% |
REGN | 88.3B | 12.7B | -1.90% | 19.84% | 20.53 | 6.97 | -10.94% | -24.40% |
ALNY | 21.4B | 1.2B | -9.89% | -15.37% | -20.15 | 17.32 | 39.94% | -8.44% |
SRPT | 11.2B | 1.0B | 4.78% | 8.17% | -12.32 | 11.15 | 20.15% | -79.16% |
UTHR | 10.4B | 2.1B | -3.76% | 7.10% | 11.99 | 4.95 | 18.01% | 38.16% |
MID-CAP | ||||||||
BPMC | 3.0B | 225.6M | -0.48% | -26.20% | -5.42 | 13.31 | -2.11% | 21.02% |
MDGL | 2.8B | - | -14.43% | 145.38% | -8.58 | - | - | -28.88% |
RARE | 2.6B | 402.9M | -0.46% | -15.55% | -3.61 | 6.46 | 20.50% | -42.46% |
MRTX | 2.4B | 27.2M | 9.19% | -41.38% | -3.24 | 87.87 | - | -14.43% |
SMALL-CAP | ||||||||
CYTK | 3.1B | - | -6.35% | -39.96% | -7.31 | 33.28 | 34.30% | -149.91% |
CPRX | 1.3B | 302.9M | -14.43% | -0.82% | 11.15 | 4.25 | 77.72% | 112.02% |
MGNX | 288.6M | 152.5M | -11.24% | 54.82% | 38.75 | 1.89 | 127.84% | 103.41% |
CRBP | 30.1M | - | 1.72% | 3677.78% | -0.65 | - | - | -31.51% |
1.2%
-0.4%
60.7%
100%
100%
89.2%
Y-axis is the maximum loss one would have experienced if Corbus Pharmaceuticals Holdings was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 | 2017Q2 | 2017Q1 | 2016Q4 |
Revenue | -42.7% | 882 | 1,540 | 2,673 | 2,823 | 3,937 | 5,853 | 7,212 | 36,020 | 36,144 | 35,497 | 33,998 | 5,758 | 4,822 | 2,895 | 2,600 | 2,097 | 2,440 | 2,816 | 2,762 | 2,809 | 1,911 |
Operating Expenses | -16.8% | 56,871 | 68,343 | 89,575 | 111,162 | 126,747 | 135,041 | 127,523 | 116,487 | 113,248 | 103,003 | 91,305 | 77,163 | 61,570 | 52,914 | 44,678 | 39,072 | 35,003 | 32,089 | - | - | - |
S&GA Expenses | -23.8% | 16,417 | 21,551 | 23,955 | 26,122 | 28,480 | 29,396 | 27,249 | 24,718 | 23,643 | 21,105 | 18,751 | 16,531 | 12,956 | 11,794 | 10,743 | 9,634 | 8,964 | 8,957 | - | - | - |
R&D Expenses | -33.6% | 31,062 | 46,792 | 65,619 | 85,040 | 98,267 | 105,645 | 100,274 | 91,769 | 89,605 | 81,898 | 72,554 | 60,632 | 48,614 | 41,120 | 33,934 | 29,438 | 26,039 | 23,132 | - | - | - |
Interest Expenses | 13.6% | -1,830 | -2,119 | -2,181 | -1,767 | -1,028 | -188 | 559 | 551 | 1,228 | 302 | 14.00 | 11.00 | 10.00 | 10.00 | 13.00 | 13.00 | 12.00 | 12.00 | - | - | - |
Net Income | -3.7% | -45,640 | -43,991 | -76,710 | -97,677 | -111,269 | -129,238 | -115,133 | -74,875 | -71,453 | -62,179 | -55,989 | -70,211 | -55,672 | -49,059 | -41,424 | -36,651 | -32,421 | -29,298 | - | - | - |
Net Income Margin | -81.2% | -51.76* | -28.57* | -28.70* | -29.55* | -28.26* | -8.83* | -4.55* | -2.08* | -1.98* | -1.75* | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | 14.9% | -48,237 | -56,653 | -84,820 | -93,914 | -100,170 | -105,851 | -96,822 | -86,772 | -48,463 | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -15.3% | 44.00 | 52.00 | 66.00 | 74.00 | 82.00 | 96.00 | 108 | 120 | 121 | 140 | 102 | 96.00 | 98.00 | 65.00 | 49.00 | 68.00 | 84.00 | 101 | 47.00 | 61.00 | 70.00 |
Current Assets | -16.6% | 38.00 | 46.00 | 60.00 | 67.00 | 75.00 | 88.00 | 100 | 112 | 112 | 130 | 92.00 | 85.00 | 88.00 | 55.00 | 38.00 | 58.00 | 75.00 | 93.00 | 44.00 | 58.00 | 68.00 |
Cash Equivalents | 14.0% | 8.00 | 7.00 | 17.00 | 12.00 | 26.00 | 57.00 | 25.00 | 37.00 | 36.00 | 67.00 | 85.00 | 82.00 | 63.00 | 47.00 | 32.00 | 55.00 | 73.00 | 90.00 | 42.00 | 56.00 | 65.00 |
Net PPE | -11.1% | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 | 5.00 | 5.00 | 5.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
Liabilities | -2.8% | 34.00 | 35.00 | 33.00 | 32.00 | 33.00 | 35.00 | 39.00 | 42.00 | 44.00 | 49.00 | 57.00 | 67.00 | 50.00 | 43.00 | 43.00 | 38.00 | 37.00 | 59.00 | 19.00 | 18.00 | 15.00 |
Current Liabilities | 14.1% | 16.00 | 14.00 | 13.00 | 17.00 | 16.00 | 15.00 | 17.00 | 17.00 | 19.00 | 24.00 | 32.00 | 41.00 | 42.00 | 35.00 | 35.00 | 31.00 | 29.00 | 52.00 | 18.00 | 17.00 | 13.00 |
LT Debt, Non Current | -19.0% | 11.00 | 14.00 | 16.00 | 9.00 | 12.00 | 14.00 | 16.00 | 19.00 | 18.00 | 18.00 | 18.00 | 18.00 | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -42.2% | 10.00 | 16.00 | 33.00 | 42.00 | 49.00 | 61.00 | 69.00 | 78.00 | 77.00 | 92.00 | 45.00 | 29.00 | 48.00 | 23.00 | 6.00 | 30.00 | 47.00 | 42.00 | 28.00 | 43.00 | 55.00 |
Retained Earnings | -2.1% | -418 | -409 | -392 | -381 | -372 | -359 | -349 | -339 | -337 | -320 | -304 | -295 | -260 | -222 | -192 | -166 | -145 | -147 | -121 | -104 | -89.46 |
Additional Paid-In Capital | 0.4% | 428 | 426 | 425 | 423 | 422 | 420 | 419 | 417 | 414 | 412 | 349 | 325 | 309 | 245 | 199 | 196 | 193 | 190 | 149 | 147 | 145 |
Shares Outstanding | 4.9% | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Cashflow (Last 12 Months) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 10.5% | -37,615 | -42,044 | -37,544 | -39,792 | -31,690 | -36,989 | -48,183 | -56,705 | -84,815 | -93,894 | -99,685 | -104,023 | -93,856 | -83,640 | -45,720 | -37,223 | -28,983 | -18,149 | -30,067 | -25,116 | -22,601 |
Share Based Compensation | -13.4% | 4,465 | 5,154 | 5,720 | 6,244 | 7,498 | 8,492 | 9,480 | 10,028 | 11,060 | 11,901 | 12,458 | 13,214 | 12,561 | 12,030 | 11,982 | 10,834 | 9,815 | 8,814 | 7,610 | 7,121 | 6,513 |
Cashflow From Investing | 374.8% | 20,166 | -7,338 | 30,074 | 15,117 | 21,372 | 26,970 | -73,416 | -70,187 | -70,527 | -57,445 | -484 | -1,828 | -2,965 | -3,132 | -2,742 | -1,700 | -612 | -1,104 | -2,300 | -2,630 | -2,570 |
Cashflow From Financing | 108.9% | 28.00 | -319 | -533 | 1* | 8.00 | 83.00 | 60,823 | 81,790 | 128,625 | 172,355 | 154,875 | 133,892 | 87,136 | 43,471 | 38,463 | 38,114 | 38,074 | 38,218 | 11,420 | 46,610 | 46,616 |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Operating expenses: | ||||
Research and development | $ 4,248,705 | $ 2,499,642 | $ 17,637,048 | $ 5,785,878 |
General and administrative | 3,940,286 | 4,840,368 | 7,848,968 | 10,071,291 |
Litigation settlement | 0 | 5,000,000 | 0 | 5,000,000 |
Total operating expenses | 8,188,991 | 12,340,010 | 25,486,016 | 20,857,169 |
Operating loss | (8,188,991) | (12,340,010) | (25,486,016) | (20,857,169) |
Other income (expense), net: | ||||
Other income (expense), net | 182,657 | (208,683) | 412,164 | (402,034) |
Interest income (expense), net | (775,586) | (490,339) | (1,453,608) | (949,248) |
Foreign currency exchange gain (loss), net | (1,921) | (209,856) | (1,193) | (477,679) |
Other expense, net | 594,850 | (908,878) | (1,042,637) | (1,828,961) |
Net loss | $ (8,783,841) | $ (13,248,888) | $ (26,528,653) | $ (22,686,130) |
Earnings Per Share, Basic | $ (2.05) | $ (3.18) | $ (6.27) | $ (5.44) |
Earnings Per Share, Diluted | $ 2.05 | $ (3.18) | $ (6.27) | $ (5.44) |
Weighted Average Number of Shares Outstanding, Basic | 4,277,701 | 4,170,464 | 4,229,894 | 4,170,255 |
Weighted Average Number of Shares Outstanding, Diluted | 4,277,701 | 4,170,464 | 4,229,894 | 4,170,255 |
Comprehensive loss: | ||||
Net loss | $ (8,783,841) | $ (13,248,888) | $ (26,528,653) | $ (22,686,130) |
Other comprehensive income (loss): | ||||
Change in unrealized gain (loss) on marketable debt securities | 44,681 | 50,373 | 102,304 | (56,875) |
Total other comprehensive income (loss) | 44,681 | 50,373 | 102,304 | (56,875) |
Total comprehensive loss | $ (8,739,160) | $ (13,198,515) | $ (26,426,349) | $ (22,743,005) |
Condensed Consolidated Balance Sheets - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 8,349,346 | $ 17,002,715 |
Investments | 28,216,560 | 42,194,296 |
Restricted cash | 192,475 | 192,475 |
Prepaid expenses and other current assets | 1,515,616 | 791,616 |
Total current assets | 38,273,997 | 60,181,102 |
Restricted cash | 477,425 | 477,425 |
Property and equipment, net | 1,273,602 | 1,613,815 |
Operating lease right of use assets | 3,486,416 | 3,884,252 |
Other assets | 211,943 | 155,346 |
Total assets | 43,723,383 | 66,311,940 |
Current liabilities: | ||
Notes payable | 51,157 | 353,323 |
Accounts payable | 1,505,734 | 2,173,963 |
Accrued expenses | 6,418,803 | 5,999,252 |
Derivative liability | 36,868 | 36,868 |
Operating lease liabilities, current | 1,357,240 | 1,280,863 |
Current portion of long-term debt | 7,016,096 | 2,795,669 |
Total current liabilities | 16,385,898 | 12,639,938 |
Long-term debt, net of debt discount | 11,319,365 | 15,984,426 |
License agreement payable, noncurrent | 2,500,000 | 0 |
Other long-term liabilities | 22,205 | 22,205 |
Operating lease liabilities, noncurrent | 3,975,329 | 4,675,354 |
Total liabilities | 34,202,797 | 33,321,923 |
Stockholders' equity | ||
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no sharesissued and outstanding at June 30, 2023 and December 31, 2022. See Note 11 | 0 | 0 |
Common stock, $0.0001 par value; 300,000,000 shares authorized,4,422,741 and 4,171,297 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively | 442 | 417 |
Additional paid-in capital | 428,153,252 | 425,196,359 |
Accumulated deficit | (418,609,320) | (392,080,667) |
Accumulated other comprehensive loss | (23,788) | (126,092) |
Total stockholders’ equity | 9,520,586 | 32,990,017 |
Total liabilities and stockholders’ equity | $ 43,723,383 | $ 66,311,940 |